Publication | BRG white paper

The Pharmaceutical Supply Chain

Aaron Vandervelde and Eleanor Blalock

January 18, 2017

Gross Drug Expenditures Realized by Stakeholders

Within the US healthcare system, the flow of dollars in the pharmaceutical marketplace is a complex process involving a variety of stakeholders and myriad rebates, discounts, and fees—some of which are paid after a prescription drug is dispensed to the patient.

In this study, Aaron Vandervelde and Eleanor Blalock discuss the drug distribution and payment process and estimate the share of gross and net drug expenditures realized by manufacturers and other entities along the supply chain.

Read the January 2020 update.

Read the original paper and the executive summary.

This study was funded by the Pharmaceutical Research and Manufacturers of America.

BRG Experts

Related Professionals

Eleanor Blalock


Washington, DC

Aaron Vandervelde

Managing Director

Washington, DC